2018
DOI: 10.1557/mrc.2018.120
|View full text |Cite
|
Sign up to set email alerts
|

Intracellular microRNA quantification in intact cells: a novel strategy based on reduced graphene oxide-based fluorescence quenching

Abstract: Nanomaterials have been proposed as key components in biosensing, imaging, and drug-delivery since they offer distinctive advantages over conventional approaches. The unique chemical and physical properties of graphene make it possible to functionalize and develop protein transducers, therapeutic delivery vehicles, and microbial diagnostics. In this study we evaluate reduced graphene oxide (rGO) as a potential nanomaterial for quantification of microRNAs including their structural differentiation in vitro in s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 46 publications
1
1
0
Order By: Relevance
“…Additionally, we verified structural differences in single-stranded and double-stranded RNA–DNA, RNA–RNA, RNA–DNA, and DNA–DNA hybrids by analyzing the sugar–phosphate backbone at 785 cm –1 . The overall findings of the study support the applicability of spontaneous RS for the identification of single-stranded and hybridized miRNA oligomers . Our future efforts will be directed toward evaluating the potential of this technique on clinical samples and designing a multiplex graphene-based biosensor for simultaneous detection of multiple miRNAs.…”
Section: Discussionsupporting
confidence: 61%
“…Additionally, we verified structural differences in single-stranded and double-stranded RNA–DNA, RNA–RNA, RNA–DNA, and DNA–DNA hybrids by analyzing the sugar–phosphate backbone at 785 cm –1 . The overall findings of the study support the applicability of spontaneous RS for the identification of single-stranded and hybridized miRNA oligomers . Our future efforts will be directed toward evaluating the potential of this technique on clinical samples and designing a multiplex graphene-based biosensor for simultaneous detection of multiple miRNAs.…”
Section: Discussionsupporting
confidence: 61%
“…29 The obtained results confirmed already published data, where GOantisense miRNA-21 complex targeting miRNA-21 was found to effectively reduce the expression of miRNA-21 in cancer cells and inhibit their proliferation and migration. 30,31 Moreover, our studies showed that GO-antisense miRNA-21 could modify the inflammatory response by affecting the cytokine expression level. IL-6, as an inflammatory cytokine, regulates the inflammatory reaction and increased cell proliferation and angiogenesis in cancer cells.…”
mentioning
confidence: 78%
“…28 GO has been shown to regulate cytokine protein expression 29 in glioblastoma by delivering therapeutic agents that target specific cytokines or cytokine pathways. 30 GO in glioma cells also regulated the protein expression level of IL-6, IL-8, and MCP-1 by the activation of the NF-κB signaling pathway. 31 The downregulation of IL-6 and Il-8 was also correlated with decreased levels of angiogenesis in glioma in an in ovo cancer model.…”
Section: Dovepressmentioning
confidence: 92%
“…[45][46][47][48]77 Body-on-a-chip devices coupled with pharmacokinetics models aim to mimic the physiological complexity of inter-organ interactions that might be used to observe continuous or linked pharmacokinetic processes such as ADME (absorption, distribution, excretion, metabolism) of various drug administration routes, and the data obtained may be applied to construct mathematical models for prediction of drug efficacy. [78][79][80] Although the "multi-organ-on-a-chip" concept remains in its infancy, major breakthroughs have been made which includes the design of two-organs 81,82 , three-organs 83,84 , four-organs 46,85 , and tenorgans on the chip. 86…”
Section: Body-on-a-chipmentioning
confidence: 99%